Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600964 · ClinicalTrials.gov registry record · Phase 1
A Phase I/II Study of GX15-070MS in Untreated CLL
A Phase 1 study, sponsored by Gemin X.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00600964 is a Phase 1 study that has completed, run by Gemin X. The registered enrollment target is 26 participants.
The verdict
NCT00600964, a Phase 1 study, has completed, sponsored by Gemin X.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This protocol is being run to determine the best phase II dose and schedule of obatoclax in patients with previously untreated CLL.
Interventions
- DRUG GX15-070MS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2004-09 |
| Est. Completion | 2006-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00600964
The ClinicalTrials.gov registry entry for NCT00600964 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gemin X, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GX15-070MS is the first listed.
NCT00600964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00600964 about?
NCT00600964 is a clinical study titled "A Phase I/II Study of GX15-070MS in Untreated CLL". This protocol is being run to determine the best phase II dose and schedule of obatoclax in patients with previously untreated CLL.
What is the current status of trial NCT00600964?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2004-09. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00600964?
The interventions under investigation include: GX15-070MS (DRUG).
Who is sponsoring clinical trial NCT00600964?
This trial is sponsored by Gemin X, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.